发明授权
US09040494B2 RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma
有权
RNAi介导的卷曲相关蛋白-1抑制治疗青光眼
- 专利标题： RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma
- 专利标题（中）： RNAi介导的卷曲相关蛋白-1抑制治疗青光眼
-
申请号： US13429913申请日： 2012-03-26
-
公开(公告)号： US09040494B2公开(公告)日： 2015-05-26
- 发明人: Abbot F. Clark , Wan-Heng Wang , Loretta Graves McNatt , Jon E. Chatterton
- 申请人： Abbot F. Clark , Wan-Heng Wang , Loretta Graves McNatt , Jon E. Chatterton
- 申请人地址： CH
- 专利权人： NOVARTIS AG
- 当前专利权人： NOVARTIS AG
- 当前专利权人地址： CH
- 主分类号： A61K48/00
- IPC分类号： A61K48/00 ; C07H21/02 ; C07H21/04 ; C12N15/113 ; A61K38/00
摘要：
RNA interference is provided for inhibition of Frizzled Related Protein-1 mRNA expression, in particular, for treating patients having glaucoma or at risk of developing glaucoma.